wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42243689-9E40CBF6-104F-40A2-A017-3A97F5FDF6AD
Q42243689-9E40CBF6-104F-40A2-A017-3A97F5FDF6AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42243689-9E40CBF6-104F-40A2-A017-3A97F5FDF6AD
Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia.
P2860
Q42243689-9E40CBF6-104F-40A2-A017-3A97F5FDF6AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42243689-9E40CBF6-104F-40A2-A017-3A97F5FDF6AD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1a087c79ececafa7cfadea026d3bab5a48c9c70
P2860
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.